{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03931954",
      "orgStudyIdInfo": {
        "id": "D2287R00140"
      },
      "organization": {
        "fullName": "AstraZeneca",
        "class": "INDUSTRY"
      },
      "briefTitle": "Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients",
      "officialTitle": "PREPARE STUDY: PRevalence of the Eosinophilic Phenotype Among SeveRE Asthma Patients in AstraZeneca International Region. A Multinational, Cross-Sectional, Multicenter Study",
      "acronym": "PREPARE"
    },
    "statusModule": {
      "statusVerifiedDate": "2021-01",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2019-05-15",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2020-11-26",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2020-11-26",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2019-04-10",
      "studyFirstSubmitQcDate": "2019-04-26",
      "studyFirstPostDateStruct": {
        "date": "2019-04-30",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2021-01-28",
      "lastUpdatePostDateStruct": {
        "date": "2021-01-29",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "AstraZeneca",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The purpose of this cross-sectional, multicenter study is to determine the prevalence of an eosinophilic phenotype of blood eosinophil count ≥ 300 cells/mm3 among severe asthma patients who attend to sites specialized in the management of severe asthma in several countries in the AstraZeneca International Region. The prevalence of an atopic phenotype and asthma control, will also be studied.",
      "detailedDescription": "To determine the prevalence of an eosinophilic phenotype of blood eosinophil count ≥ 300 cells/mm3 among severe asthma patients attending their routine clinical visit at sites specialized in the management of severe asthma in several countries in the AstraZeneca International Region. The prevalence of an atopic phenotype and the status of asthma control, will also be studied. It is expected that this study will contribute to the understanding of severe asthma, ultimately helping to inform therapeutic decisions and addressing patients' needs."
    },
    "conditionsModule": {
      "conditions": [
        "Severe Asthma"
      ],
      "keywords": [
        "eosinophilic asthma",
        "severe asthma",
        "prevalence",
        "phenotype",
        "atopic phenotype",
        "eosinophilic phenotype"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": false,
      "designInfo": {
        "observationalModel": "CASE_ONLY",
        "timePerspective": "CROSS_SECTIONAL"
      },
      "enrollmentInfo": {
        "count": 794,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Study population",
          "description": "Patients completing the inclusión criteria"
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Blood Eosinophil count",
          "description": "The level of eosinophils in the blood will be assessed from this blood sample and reported",
          "timeFrame": "There is only one study visit. During that study visit the sample will be collected"
        },
        {
          "measure": "Total serum IgE",
          "description": "Total serum IgE will be assessed from this blood sample and reported",
          "timeFrame": "There is only one study visit. during that visit the sample will be collected"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria\n\nPatients must fulfil all of the following inclusion criteria to be included in the study:\n\n* Male or female patient, aged 12 years or older by the time of study entry\n* Patient visiting a participating center for a routine clinical appointment\n* Patient is willing and able to provide a blood sample for IgE and eosinophil levels determination as part of their routine clinical visit\n* Diagnosis of severe asthma for at least one year as defined by:\n* Treatment with guidelines-suggested medications for Global Initiative for Asthma (3) steps 4-5 asthma\n* Patients or their legal guardian, who voluntarily sign and date the informed consent form prior to study entry.\n\nExclusion Criteria\n\n* Patients with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory condition beyond severe asthma\n* An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study Patients who are currently under a biologic therapy to treat their severe asthma",
      "healthyVolunteers": false,
      "sex": "ALL",
      "stdAges": [
        "CHILD",
        "ADULT",
        "OLDER_ADULT"
      ],
      "studyPopulation": "The study population will include patients from 12 years and older with severe asthma, as per the definition of the GINA 2018 Guidelines (GINA, 2018). Patients will be identified and invited to participate in the study consecutively, as they attend their routine clinical visit at the research centers.\n\nTo be included in the study, each patient should meet all the inclusion criteria and none of the exclusion criteria described in the sections below. Patients should provide written, informed consent prior to any study-specific procedures.\n\nThe enrolment period will be approximately 8 months or until the required number of patients has been included, whichever occurs first",
      "samplingMethod": "NON_PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Maarten beekman, MD",
          "affiliation": "medical lead respiratory International",
          "role": "STUDY_CHAIR"
        },
        {
          "name": "Monica Olmos, MD",
          "affiliation": "Study delivery lead",
          "role": "STUDY_CHAIR"
        }
      ],
      "locations": [
        {
          "facility": "Research Site",
          "city": "Buenos Aires",
          "country": "Argentina",
          "geoPoint": {
            "lat": -34.61315,
            "lon": -58.37723
          }
        },
        {
          "facility": "Research Site",
          "city": "Rosario",
          "country": "Argentina",
          "geoPoint": {
            "lat": -32.94682,
            "lon": -60.63932
          }
        },
        {
          "facility": "Research Site",
          "city": "Curicó",
          "country": "Chile",
          "geoPoint": {
            "lat": -34.98279,
            "lon": -71.23943
          }
        },
        {
          "facility": "Research Site",
          "city": "Santiago",
          "country": "Chile",
          "geoPoint": {
            "lat": -33.45694,
            "lon": -70.64827
          }
        },
        {
          "facility": "Research Site",
          "city": "Barranquilla",
          "country": "Colombia",
          "geoPoint": {
            "lat": 10.96854,
            "lon": -74.78132
          }
        },
        {
          "facility": "Research Site",
          "city": "Bogotá",
          "country": "Colombia",
          "geoPoint": {
            "lat": 4.60971,
            "lon": -74.08175
          }
        },
        {
          "facility": "Research Site",
          "city": "Bucaramanga",
          "country": "Colombia",
          "geoPoint": {
            "lat": 7.125,
            "lon": -73.11895
          }
        },
        {
          "facility": "Research Site",
          "city": "Pereira",
          "country": "Colombia",
          "geoPoint": {
            "lat": 4.81428,
            "lon": -75.69488
          }
        },
        {
          "facility": "Research Site",
          "city": "San José",
          "country": "Costa Rica",
          "geoPoint": {
            "lat": 9.93388,
            "lon": -84.08489
          }
        },
        {
          "facility": "Research Site",
          "city": "Guadalajara",
          "country": "Mexico",
          "geoPoint": {
            "lat": 20.67738,
            "lon": -103.34749
          }
        },
        {
          "facility": "Research Site",
          "city": "Mérida",
          "country": "Mexico",
          "geoPoint": {
            "lat": 20.967,
            "lon": -89.62318
          }
        },
        {
          "facility": "Research Site",
          "city": "Puebla City",
          "country": "Mexico",
          "geoPoint": {
            "lat": 19.04778,
            "lon": -98.20723
          }
        },
        {
          "facility": "Research Site",
          "city": "San Juan del Río",
          "country": "Mexico",
          "geoPoint": {
            "lat": 20.38897,
            "lon": -99.99637
          }
        },
        {
          "facility": "Research Site",
          "city": "Villahermosa",
          "country": "Mexico",
          "geoPoint": {
            "lat": 17.98625,
            "lon": -92.93928
          }
        },
        {
          "facility": "Research Site",
          "city": "Dammam",
          "country": "Saudi Arabia",
          "geoPoint": {
            "lat": 26.43442,
            "lon": 50.10326
          }
        },
        {
          "facility": "Research Site",
          "city": "Jeddah",
          "country": "Saudi Arabia",
          "geoPoint": {
            "lat": 21.49012,
            "lon": 39.18624
          }
        },
        {
          "facility": "Research Site",
          "city": "Riyadh",
          "zip": "111511",
          "country": "Saudi Arabia",
          "geoPoint": {
            "lat": 24.68773,
            "lon": 46.72185
          }
        },
        {
          "facility": "Research Site",
          "city": "Riyadh",
          "country": "Saudi Arabia",
          "geoPoint": {
            "lat": 24.68773,
            "lon": 46.72185
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "35177038",
          "type": "DERIVED",
          "citation": "Al-Jahdali H, Wali S, Albanna AS, Allehebi R, Al-Matar H, Fattouh M, Beekman M. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study. BMC Pulm Med. 2022 Feb 17;22(1):67. doi: 10.1186/s12890-022-01856-9."
        }
      ],
      "seeAlsoLinks": [
        {
          "label": "CSR Synopsis",
          "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D2287R00140&amp;attachmentIdentifier=706cb728-2854-4287-a5b9-0d84bcd0a71c&amp;fileName=CSR_PREPARE_V_0.5_CTT_with_Milestones_Combined.pdf&amp;versionIdentifier="
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04",
      "removedCountries": [
        "Hong Kong",
        "Lebanon"
      ]
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D001249",
          "term": "Asthma"
        },
        {
          "id": "D011657",
          "term": "Pulmonary Eosinophilia"
        }
      ],
      "ancestors": [
        {
          "id": "D001982",
          "term": "Bronchial Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D008173",
          "term": "Lung Diseases, Obstructive"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        },
        {
          "id": "D017681",
          "term": "Hypereosinophilic Syndrome"
        },
        {
          "id": "D004802",
          "term": "Eosinophilia"
        },
        {
          "id": "D007960",
          "term": "Leukocyte Disorders"
        },
        {
          "id": "D006402",
          "term": "Hematologic Diseases"
        },
        {
          "id": "D006425",
          "term": "Hemic and Lymphatic Diseases"
        }
      ]
    }
  },
  "hasResults": false
}